Signifor — United Healthcare
Cushing’s disease
Initial criteria
- Diagnosis of endogenous Cushing’s disease (i.e., hypercortisolism is not a result of chronic administration of high dose glucocorticoids)
- AND
- One of the following:
- Pituitary surgery has not been curative for the patient
- OR
- Patient is not a candidate for pituitary surgery
Reauthorization criteria
- Documentation of positive clinical response to Signifor therapy
Approval duration
12 months